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Available online 12 January 2016There are several genetic diseases with a wide spectrum of congenital bone stigmata in association to cutaneous
and visceral benign and malignant neoplasms. Gorlin–Goltz syndrome, also named nevoid basal cell carcinoma
syndrome, is an autosomal dominant systemic disease with almost complete penetrance and high intra-
familial phenotypic variability, caused by germline mutations of the gene PTCH1. The syndrome is characterized
by unusual skeletal changes and high predisposition to the development of multiple basal cell carcinomas,
odontogenic keratocysts tumors and other visceral tumors. The Gorlin syndrome, clinically deﬁned as distinct
syndrome in 1963, existed during Dynastic Egyptian times, as revealed by a costellation of skeletal ﬁndings com-
patible with the syndrome inmummies dating back to 3000 years ago and, most likely, in the ancient population
of Pompeii. These paleogenetic and historical evidences, together with the clinical and biomolecular modern ev-
idences, conﬁrm the quite benign behavior of the syndrome and the critical value of the multiple and synchro-
nous skeletal anomalies in the recognition of these rare and complex genetic disease.
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There are several genetic diseases with a wide spectrum of congen-
ital bone stigmata in association to cutaneous and visceral signs and
symptoms. The recognition of the inherited skeletal abnormalities, par-
ticularly when uncommon, constitute a critical tool to obtain an early
recognition of these syndrome both in the archeological remains and
in the current population (Ponti et al., 2013a, 2013b). Among the hered-
itary tumor syndromes associated to unique skeletal ﬁndings, Nevoid
Basal Cell Carcinoma Syndrome (NBCCS; also known as Gorlin syn-
drome; OMIM #109400) is an autosomal dominant skin disease with
an almost complete penetrance and a high intra-familial phenotypic
variability, caused by germline mutations of the gene PTCH1 (Lo
Muzio, 2008; Lo Muzio et al., 2013). The syndrome is characterized by
an increased predisposition to the development of multiple basal cell
carcinomas (BCC) in association with odontogenic keratocystic tumors
(OKT), ameloblastoma (AML), visceral tumors (medulloblastomas,rome; BCC, basal cell carcinoma;
; CT, computerized tomography;
ent of Surgical, Medical, Dental
Oncological and Regenerative
na 41124, Italy.ovarian and cardiac ﬁbromas, rhabdomyosarcomas) and unusual skele-
tal changes (Kiwilsza and Sporniak-Tutak, 2012). The NBCCS classic
phenotype is characterized by the presence of speciﬁc bone abnormali-
ties of the skull (frontal and parietal bossing, macrocephaly, calciﬁca-
tions of the falx cerebri, brain tumors and maxillary or mandibular
keratocystic ameloblastomas) and of other skeletal segments (biﬁd
ribs, syndactyly, polydactyly) that sometimes facilitate identiﬁcation
and clinical diagnosis (Kiwilsza and Sporniak-Tutak, 2012). The
aforementioned abnormalities of the neurocranium and of the
splanchnocranium are the main cause of the NBCCS typical facies, char-
acterized by asymmetry, hypertelorism and fronto-parietal bossing,
that sometimes is the only aid to an early clinical diagnosis (Fig.1).
The NBCCS estimated prevalence is 1 per 40–57,000 (Farndon et al.,
1992; Pratt and Jackson, 1987). In Italy, the incidence of the disease
(1:256,000) (Lo Muzio et al., 2013) seems to be lower than in
Australia (1:164,000) (Shanley et al., 1994) and the United Kingdom
(1:55,600) (Evans et al., 1993).
2. From the ﬁrst description of NBCCS to PTCH1 gene identiﬁcation
The ﬁrst description of a patient affected by the NBCCSwas probably
published in 1894 when Jarisch described a 22-year old patient affected
by short stature, milia, low mentality, marked scoliosis and multiple
basal cell carcinoma since the age of 14, one of these skin lesions having
Fig. 1. Pictures of patients (A–H) affected by NBCCS, reproduced from the original manuscript by Gorlin et al. (1965).
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thor, in its original manuscript, described a series of patients affected by
multiple skin lesions, most likely basal cell carcinomas, in association to
systemic anomalies, and probably the aforementioned 22-years old pa-
tient, was clearly affected by NBCCS, showing the main clinical and his-
tological features of the syndrome.
A relationship between developmental defects and multiple basal
cell carcinoma was reported by Binkley and Johnson in 1951 (Binkley
and Johnson, 1951), and Howell and Caro, 1959 (Howell and Caro,
1959). Only in 1960, Gorlin and Goltz described that the association of
multiple nevoid basal cell carcinoma, cysts of the jaw and skeletal
anomalies, most commonly biﬁd rib, was consistent enough to consider
their occurrence as a distinct syndrome (Gorlin and Chaudhary, 1960;
Gorlin et al., 1963). The clinical criteria for the diagnosis of NBCCSTable 1
NBCCS signs and symptoms with their relative frequency proposed by Gorlin R in 1963.
From the original tabulationwe here report only the skin, oral and skeletalmanifestations.
Signs and symptoms Relative
frequency
Skin
A1 Multiple nevoid basal-cell carcinoma +++
A2 Palmar dyskeratosis (porokeratosis of Mantoux) ++
A3 Milia; cysts, especially extremities ++
A4 Fibromas and/or neuroﬁbromas, especially extremities +
Oral manifestations
B1 Multiple jaw cysts +++
B2 Mild mandibular prognathism ++
B3 Fibrosarcoma jaws (?) +
B4 Ameloblastoma +
Skeletal system
C1 Rib: biﬁd, synostosis, partial agenesis, or cervical rudimentary +++
C2 Vertebrae: scoliosis, cervical or thoracic fusion ++
C3 Frontal and biparietal bossing ++
C4 Shortened metacarpals ++
C5 Deformed chest +
Central nervous system
D3 Calciﬁcation dura (falx, tentorium) choroid ++
Eye
Dystopia canthorum, hypertelorism ++proposed by Gorlin in the 1965 were summarized in Table 1 (Fig.1).
The developmental defects, described by Gorlin, that are distinctive of
the syndrome include: intracranial calciﬁcation, fused, biﬁd and splayed
ribs, calciﬁcations of the falx cerebri and frontal bossing (Table 1).
Gorlin's triad of original criteria was later enlarged with other addi-
tional features such as other skeletal anomalies and the presence of
palmo-plantar pits. The description of palmo-plantar pits was done by
Calnan, that deﬁned this feature as a peculiar dyskeratosis of the
palms and soles (Calnan, 1953). More precisely, these alterations are
caused by the partial or complete absence of the stratum corneum in
areas with diameter from 1 to 3 mm.
Diagnostic NBCCS clinical criteria were deﬁned by Evans DG (Evans
et al., 1993) and revised by Kimonis in 1997 (Kimonis et al., 1997). Ac-
cording to Kimonis et al., twomajor or onemajor and twominor criteria
should be present for the diagnosis of NBCCS (Table 2). Among the ﬁve
major criteria the bone stigmata comprise the lamellar calciﬁcation of
the falx cerebri under age 20 and the histologically conﬁrmed
odontogenic (jaw) keratocyst; among the sevenminor criteria the skel-
etal abnormalities include the macrocephaly, the cleft lip/palate andTable 2
Diagnostic criteria for NBCCS proposed by Kimonis in 2004 (2major or 1 major
and 2 minor criteria, or a ﬁrst degree relative with NBCCS and 1 major or 2 mi-
nor features).
Major criteria
More than 2 BCCs or one BCC under the age of 20 years
Odontogenic keratocysts of the jaw proven by histology
Three or more palmar or plantar pits
Lamellar calciﬁcation of the falx cerebri
Rib anomalies (biﬁd, synostosed, hypoplastic)
Ovarian ﬁbroma
Medulloblastoma
Flame shaped lucencies of the phalanges
Brachymetacarpaly in all 4 limbs
First degree relative with NBCCS
Minor features
Any one of the following features:
Spina biﬁda occulta or other vertebral anomalies
Brachymetacarpaly in at least one limb
Hypertelorism or telcanthus
Frontal bossing
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splayed ribs.
However, clinical and radiologic analyses led to many revisions of
the diagnostic criteria over time. Regarding the skeletal anomalies,
Kimonis in his NBCCS families reported odontogenic keratocysts in
74% of patients, calciﬁcation of the diaphragm of sella turcica in 68% of
patients, calciﬁcation of the falx cerebri in 65% of patients, coarse face
in 54% of patients, macrocephaly in 50% of patients, hypertelorism in
42% of patients, frontal bossing in 27% of patients, calciﬁcation of the
tentorium cerebelli in 20% of patients, sternal abnormalities in 13% of
patients, biﬁd ribs in 26% of patients, hemivertebrae in 15% of patients
and vertebral fusion in 10% of patients (Kimonis et al., 1997).
In 2004 the same authors (Kimonis et al., 2004) enlarged the popu-
lation studying additional skeletal features inNBCCS syndrome patients,
with the following results: biﬁd ribs were conﬁrmed in 26% of patients,
nuchal ligament calciﬁcation was present in 18%, other ribs anomalies
(fusion, hypoplasia or aplasia) were present in 16%, hemivertebrae
were conﬁrmed in 15%, deformations were present in 14%, clavear ab-
normalities were present in 12%, vertebral fusion were conﬁrmed in
10% of patients, phalangeal foot polydactyly was present in 4%. In
2011, Bree AF and Shah MR (Bree and Shah, 2011) proposed less strin-
gent criteria for NBCCS diagnosis suggesting that medulloblastoma
should be considered a major and not a minor criteria, increasing
early detection of the underlying syndrome, since it typically manifest
in children aged 2 years and younger (Table 2).
In our report published in 2012, we proposed a restoration of a
neglected criterion for NBCCS recognition: the ameloblastoma (AML)
(Ponti et al., 2012a, 2012c). In fact, althoughmanuscripts in the literature
reported the association between AML and NBCCS (Jensen and Roser,
1978; Schultz et al., 1987; Eslami et al., 2008; Ackermann et al., 1988), in-
cluding the ﬁrst cases reported by Gorlin R et al. which suggested that
AML as associated Gorlin–Goltz sign (Gorlin et al., 1963), themost recent
wider criteria do not include this odontogenic tumor among the NBCCS
criteria yet (Kimonis et al., 2004). In 2014,we performed a clinical and ra-
diologic characterization of the NBCCS related cranio-facial and other
skeletal anomalies using 3D and helical CT scan reporting skeletal stigma-
ta as macrocephaly, positional plagiocephaly, skull base and sphenoid
asymmetry, biﬁdity of multiple ribs and giant multilocular odontogenic
jaw cysts and extensive multilamellar calciﬁcations of falx cerebri,
tentorium, falx cerebelli and of the atlanto-occipital ligament (Fig. 2). In
the same study, in addition to the sphenoid asymmetry, we focused our
attention on the value of biﬁd ribs, which are very uncommon in the gen-
eral populations (estimated prevalence of 0.15–3.4% in the generalFig. 2. Radiologic CT images of NBCCS patients showing fronto-parietal bossing (A,B), odontogen
(F,G), biﬁd ribs (H–L).population vs. estimated prevalence of 26% in the NBCCS patients)
(Kimonis et al., 2004, Lo Muzio, 2008), and suggested their inclusion as
a novel major criteria which may be useful for the recognition and char-
acterization of misdiagnosed cases (Ponti et al., 2014) (Fig 2).
Further clinical and radiologic evaluations of a wider population of
PTCH1mutated gene-carriers would be helpful to establish the clinical
impact of the different skeletal stigmata among the NBCCS major and
minor diagnostic criteria which should be considered dynamic entities
that can be improved and better characterized.
Themolecular pathogenesis of NBCCS has been known since the dis-
covery in 1996 of the germlinemutations on the PTCH1 gene. Since then,
about 280 germline mutations have been described worldwide so far
(Pastorino et al., 2012). The PTCH1, or the human homolog 1 of the Dro-
sophila Patched gene, which ismapped on chromosome9q22.3, consists
of 23 exons and encodes an integral membrane protein of 1447 amino
acids, Patched 1 (PTCH1) with 12 transmembrane regions, 2 extracellu-
lar loops, and a putative sterol-sensing domain (Ponti et al., 2012b).
The SHH signaling pathway plays an important role in the mamma-
lian embryonic development ofmany structures such as the neural tube,
axial skeleton, limbs, lungs, skin, hair follicles, and teeth. SHH signaling
also regulates growth and determines the shape of teeth (Dassule
et al., 2000). PTCH1 mutation spectrum includes point mutations,
small and large deletions, insertions and splicing mutations (Jones
et al., 2011). Heterozygosity for PTCH1 due to inherited germline muta-
tion is likely to give rise to the developmental anomalies seen in NBCCS.
Subsequent postnatal loss of the other allele by mutation or silencing
can lead to unregulated downstream proliferative activity, which in-
duces the cutaneous phenotype and other neoplasm (Levanat et al.,
1996).
The PTCH1mutations are responsible for the clinical expression of
the disease and can be found in a large amount of patients exhibiting
a classic phenotype. Differently from other cancer predisposing syn-
dromes, NBCCS doesn't show the correlations between genotype–phe-
notype (Ponti et al., 2012b, 2013b) and its wide phenotypic variation
does not appear to be related to the type of PTCH1 mutation, nor to
any founder effect. Normally the founder effect is deﬁned as an ancestral
mutation, that was introduced in the same population by a common an-
cient progenitor, and that can be found in different affected families ap-
parently unrelated by any kinship, and living in the same geographic
area. This is partly due to the relatively recent identiﬁcation of the
gene responsible of the syndrome and partly to the difﬁculty of
extracting “pure”DNA from the ancient bones that are suggestive of pa-
tients affected by NBCCS or other genetic skeletal disease.ic abnormalities and cysts (C), calciﬁcations of the falx cerebri (D,E), sphenoid asymmetry
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Although the spectrum of signs and symptoms associated with
Gorlin Syndrome was described in detail by Gorlin in 1960, some
archeologic ﬁndings document the presence of this syndrome in the an-
cient Egypt, more than 3000 years before Gorlin's manuscript.
Three Egyptian skeletons of the Dynastic period (between the V and
XI dynasty, 2450–1955 BC) present bone aberrations compatible with
the diagnosis of Gorlin Syndrome. They came from the graves of Assyut
andGebelein andwere collected among the skeletons that belong to the
“G. Marro” Egyptian anthropological collection (Museum of Anthropol-
ogy and Etnography of Turin). The specimenswere collected during the
excavation of the Italian Archeological Mission in Egypt (1903–1937),
under the direction of the Turin Egyptian Museum. The collection con-
sists of mummiﬁed specimens (20 complete mummies and 80 heads)
and bones (650 complete skeletons and 1300 isolated skulls) (Leigh,
1934; Boano et al., 2006; Ponti et al., 2014).
The two skeletons excavated at Assyut (case 1, E225 and case 2,
E235) were characterized by frontal bossing, multiple bony cavities
(probably cysts) of mandible and maxilla; multiple biﬁd ribs (in the
case 2 six biﬁd ribs are present); sacrum with incomplete fusion of the
dorsal laminae; occipital asymmetry; relative shortening of 4th meta-
carpals; scoliosis and enlargement of the sella turcica (Satinoff and
Wells, 1969) (Figs. 3, 4): these ﬁndings support the diagnosis of
NBCCS with different major criteria met (odontogenic keratocysts,
biﬁd ribs, affected family members, etc.).
The other skeleton with biﬁd rib compatible with the diagnosis of
Gorlin Syndrome (GED 44, E22) come from a single grave at Gebelein
(upper Egypt) and are referable to a child of around 4 years (Boano
et al., 2006). Although in this skeleton the biﬁd rib is not associated
with any other skeletal alteration in the axial or appendicular skeleton,
the suspicion of the Gorlin syndrome is clear due to the crucial role of
these coast anomalies in establishing a diagnosis of the genetic disease,
particularly in young children (Veenstra-Knol et al., 2005).
4. Gorlin–Goltz bone stigmata in the Pompeian and Herculaneum
archeological bones collection
The archeological excavations in Pompeii ofﬁcially started in 1748
due to thewill of the Emperor Charles III of Spain, king of the Two Sicilies.Fig. 3. Pictures of skeletal anomalies reproduced from the manuscript by Satinoff et al. from 1
relative shortening of 4th metacarpals (D), biﬁd ribs (E–G), incomplete fusion of the sacral lamOver the centuries, in addition to the architectonical structures, the
archeological remains comprised many items of the common life, such
as furnitures and pottery,mingledwith human and animal bones. Some-
times it was possible to isolate the whole skeleton, or to create identical
molds, other times only separate skeletal segments were isolated and
found.
To date there are few paleogenetic studies that analyzed the animal
remains (especially horse's) (Di Bernardo et al., 2004). Only a minority
of them focus on the anthropometric values of human bones, and
even less studies explore the molecular-genetic aspects (Di Bernardo
et al., 2009; Cipollaro, 2011).
One of our recent studies at the University of Modena and Reggio
Emilia, in collaboration with the Superintendence of Pompei, was
conducted in order to characterize the clinical and genetic features
of the skeletal remains collected in the Forum Baths from Pompeii
archeological site. The anthropometric analysis of the skeletal
remains was aimed to the identiﬁcation of the likely presence of
hereditary syndromes (especially the Gorlin syndrome) affecting
the roman population in A.D. 79. The speciﬁc aim of the study was
the identiﬁcation of the skeletal alteration characteristic of the
NBCCS. The analysis of 100 skulls stored in the Forum Baths was con-
ducted in order to measure the main anthropometric values of the
horizontal cranial index and the vertical cranial index, also called
index of Broca (ICOB), that are useful in order to quantify some mor-
phologic features of the head. The anthropometric data were
collected from 100 skulls and 20 mandibular bones of adults stored
in the Forum Baths in archeological site from Pompeii. The measure-
ment comprised the determination of the horizontal cranial index
and the vertical cranial index, also named horizontal and vertical
cranial indices of Broca. In particular, the vertical cranial index
(ICOB) was measured on 60 intact skulls and the respective values
were analyzed in accordance with the seven categories deﬁned by
Garson (in Martin and Saller, 1956-1959).
At the archeological bone collection of Pompeii, our preliminary
study, allowed to deﬁne a signiﬁcative heterogeneity of the anthropo-
metric cranial parameters: even though the majority of the population
had a mesocranic skull (39%) with an average ICOB of 79.89, a vast per-
centage of dolicocranic skulls was identiﬁed (about 35%)with some indi-
viduals having hyperdolicocranic skulls. It was among the dolicocranic
and hyperdolicocranic portion of the population that some skulls969. In detail, the presence of asymmetric skull base (A), odontogenic keratocysts (B, C),
inae (H).
Fig. 4. Pictures acquired at the Egyptian anthropological collection (Museum of Anthropology and Etnography of Turin). The skeleton excavated at Assyut (E235) was characterized by
frontal bossing (A, B), multiple bony cavities (probably cysts) of mandible (C), occipital asymmetry (D) and biﬁd ribs (E).
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(Fig. 5).
This observation, that led us to hypothesize that some individuals of
the Pompeii populationwere affected byNBCCS,was probably the focus
of the hypothesis of the anthropologist Stefano Delle Chiaie, that in
1853, analyzed the Pompeian skulls collections and asserted that the
ancient population of Pompeii was composed by many ethnic groups
(Delle Chiaie, 1854). In fact, it was well known that the population in
Pompeii consisted of multiethnic society because of the high number
of slaves of the African or Eastern descent.
The ﬁrst ofﬁcial publication of the human skeletal remains from
Pompei was published in 1882 by Giustiniano Nicolucci (Nicolucci,
1882), that was the founder of the Institute of Anthropology of the Uni-
versity of Naples. Nicolucci didn't agree with Delle Chiaie when he de-
scribed that “some skull were globular, other ovoid and that a few were
oblong in form; the ﬁnal type of skull observed in this work was interpreted
as African, probably representing slaves who were in the service of the
wealthy citizen of Pompei”. Nicolucci though that the population of
Pompei in AD 79 was heterogeneous, but autochthonous reportingFig. 5. Pictures of selected skulls, acquired at the Forum Baths archeological skeletal collection
bossing, maxillary odontogenic cysts and asymmetry of the skull base (A–L). Reproduced with
Herculaneum and Stabia.that dolichocephalic skulls were found in the 14% cases, mesocephalic
skulls were found in the 43% population and brachycephalic skulls
were found in the remaining 43% cases.
The same ideas were presented in a recent study published by E.
Laser, that in addition to the metric evidences, also assessed the non-
metric parameters, concluding that the observed statistical deviations
in the measurement of the cranial indices, derived from intra-
population variability (of the same ethnic group) rather than inter-
population variability (of different ethnic group) (Lazer, 2011).
It's important to underline that our anthropometric results were ob-
tained from a different skeletal collection respect to the ones evaluated
by the aforementioned authors, in fact, the collection that we analyzed
were lacking some of the more unusual skeletal skulls that Nicolucci
took to Naples (D'Amore, 1979), but comprised the new skeletal re-
mains that were found and added to the collection in the last decades.
Even though a high frequency of macrocephaly and frontal bossing
was observed in the population of Pompeii, the disarticulated nature
of the Pompeian samples constituted an important limit to the analysis
of the systemic skeletal anomalies that is necessary to diagnose NBCCSof Pompeii, showing the typical NBCCS-associated alterations consisting of fronto-parietal
the permission of the Special Superintendence for the Archeological Remains of Pompeii,
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lies don't lead unequivocally to the NBCCS diagnosis, because it is not
sufﬁcient to deﬁne the patient as being affected by NBCCS, the high fre-
quency of those abnormalities in the dolicocranic population represent
an important clue to hypothesize that at least some individuals were af-
fected by NBCCS. In detail, some skulls were characterized by marked
frontal bossing and parieto-occipital bossing (signs already described
by Gorlin in 1963), asymmetry of the cranial base, and presence of mul-
tiple odontogenic cysts in the mascellary bone (Fig. 6). The analysis of
the mandible and of the ribs of those subjects would have been of
great scientiﬁc value, but unfortunately it was not possible. Regarding
the mandibular cysts, it is worth mentioning that Capasso observed
many skeletons with multiple mandibular cysts and among these four
individuals with four–ﬁve odontogenic abscesses while an individual
had a total of 8 oral abscesses (Lazer, 2011).
The observed tendency to macrocephaly and the presence of multi-
ple cases with clear asymmetry of the cranial base, with fronto–
temporo-parietal bossing in the ancient population of Pompeii is
unusual if compared to the anthropometric data found in the near city
of Herculaneum,where it was reported a presence of 47% of mesocranic
skulls, more than 25% of brachicranic skulls and a relatively low inci-
dence of hyperdolicocranic skulls (13.7%) (Capasso, 2001). The analysis
conducted by Capasso of the 162 skeletons, extracted from 1982 to
1985, took 7 years of accurate examinations and studies. In his manu-
script, entitled “I fuggiaschi di Ercolano”, Capasso focused on the paleo-
biology of the remains and tried to reconstruct the most frequent
diseases, the alimentary habits, and the life and work activities also in
children (Capasso, 2001). Among the 162 Herculaneum skeletal re-
mains it is possible to ﬁnd a skeleton in relatively good conditions,
where it can be described one of the skeletal abnormalities that is
more speciﬁc for the NBCCS: the presence of biﬁd ribs in association
with cranial base asymmetry (Fig. 7).
The subsequent steps of our paleo-pathologic research, will be pos-
sible thanks to the friendly attitude of the, Prof. Massimo Osanna, and
of the Head of the Applied Biology Laboratory, dr. Ernesto De Carolis,
and his patient technicians, will lead to the documentation through
3D TAC of the most relevant skeletal remains and the determination ofFig. 6. Pictures of selected mandibles and maxillary bones acquired at the Forum Baths archeo
odontogenic cysts (A–I). Reproduced with the permission of the Special Superintendence for tthe mutational status of PTCH1, after the laboratory procedures of an-
cient DNA extraction.
5. Conclusions
The combination of concomitant skeletal abnormalities in multiple
anatomic sites of involvement is an important aid to the diagnosis of
NBCCS. Some important semiology signs affecting the facies, as the
presence of facial asymmetry, hypertelorism, frontal and parietal
bossing, are the result of the corresponding alterations of the neuro-
and splanchnocranium (Fig. 8). Those signs are important clues both
for the clinician and the archeologist to suspect the diagnosis of
NBCCS, which should be conﬁrmed through biomolecular investiga-
tions, DNA extraction and PTCH1 sequence analysis. In particular, bone
ﬁndings are essentials to establish a diagnosis in children, in fact in
the pediatric population it is very common that the other clinical diag-
nostic criteria are lacking because they have not manifested yet. The
longevity of the syndrome can be demonstrated through the analysis
of ancient bones, which are fundamental to make paleopathological
studies and to diagnose the syndrome. Many congenital skeletal alter-
ations recovered from the remains of ancient populations that lived in
Egypt about 3000 years ago, and in Pompeii and Herculaneum about
2000 years ago, shed some light on the history of the syndrome, that
was identiﬁed as a clinically deﬁned entity only in 1963 AD. The ﬁnding
of NBCCS phenotype in many old populations demonstrates the rela-
tively benignity of NBCCS that allows the survival of the affected indi-
viduals to the fertile age, so that the germline mutations has been
preserved throughout millenniums.
The sequencing of the gene PTCH1 from ancient DNA, extracted form
skeletal remains andmummiﬁed bodies, is a necessary step for the con-
clusive diagnosis of NBCCS, and will probably allow the analysis of the
phylogenesis and of the founder effects of the mutations.
6. Summary
There are several genetic diseases with a wide spectrum of congen-
ital bone stigmata in association to cutaneous and visceral benign andlogical skeletal collection of Pompeii, showing the typical odontogenic NBCCS features of
he Archeological Remains of Pompeii, Herculaneum and Stabia.
Fig. 7. Pictures of skeletal anomalies reproduced from themanuscript by Capasso (2001). In detail, the presence of biﬁd ribs (A,B), asymmetric skull base (C,F) and fronto-parietal bossing
(D,E).
110 G. Ponti et al. / Gene 589 (2016) 104–111malignant neoplasms. Gorlin–Goltz syndrome, also named nevoid basal
cell carcinoma syndrome, is an autosomal dominant systemic disease
with an almost complete penetrance and high intra-familial phenotypic
variability, caused by germline mutations of the gene PTCH1. The
syndrome is characterized by unusual skeletal changes and high predis-
position to the development of multiple basal cell carcinomas,
odontogenic keratocysts tumors and other visceral tumors. The Gorlin
syndrome, clinically deﬁned as distinct syndrome in 1963, existedFig. 8. Pictures of clinical features of PTCH1mutated gene-carriers patients (A–H) affecteduringDynastic Egyptian times, as revealed by a constellation of skeletal
ﬁndings compatible with the syndrome in mummies dating back to
3000 years ago and, most likely, in the ancient population of Pompeii.
These paleogenetic and historical evidences, together with the clinical
and biomolecularmodern evidences, conﬁrm the quite benign behavior
of the syndrome and the critical value of the multiple and synchronous
skeletal anomalies in the recognition of these rare and complex genetic
disease.d by NBCCS, retrieved from our archive at University of Modena and Reggio Emilia.
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